P3-17-06 Final Results of a Controlled, Randomized 3-Arm Phase II Trial of EndoTAG™-1, a Cationic Liposomal Formulation of Paclitaxel Targeting Tumor Endothelial Cells, in Advanced Triple-Negative Breast Cancer (TNBC) Awada A, Bondarenko IN, Tarasova O, Bonneterre J, Nowara E, Ferrero JM, Bakshi AV, Weidenthaler H, Wilke C, Piccart MJ. Institut Jules Bordet, Brussels, Belgium; Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine; Academy of Medical Sciences of Ukraine, Kharkov, Ukraine; Centre Oscar Lambret, Lille, France; Instytut im. M.Sklodowskiej-Curie, Gliwice, Poland; Centre Antoine Lacassagne, Nice, France; Kaushalya Medical Foundation, Thane, India; Medigene AG, Martinsried, Germany.http://sabcs.org/ProgramSchedule/PosterSessions.asp?SessionGroupID=97 (06.-10.12.2011) |